Cann Group Shares Down as It Releases Quarterly Update (ASX:CAN)

By ,

Languishing pot stock Cann Group Ltd [ASX:CAN] is being punished by investors today.

The CAN share price is down 14.47% at time of writing, falling substantially as management revealed a decent quarterly result and plans for a fresh capital raise.

As you’d expect, the market didn’t respond too kindly to this news. Especially given the size of the requested capital.

Let’s dig into the details…

Decent sales, big operational costs

First, the good news.

Cann has managed to achieve just over $2.7 million in sales for the quarter. Which is a substantial portion of their unaudited $4.29 million total for the financial year.

A good sign that the cannabis producer is starting to gain some traction. Particularly from international buyers, with 21,000 of their 30,000 units sold to overseas markets.

However, this was offset by rising manufacturing costs and spending on new facilities/infrastructure — an ongoing concern that has dragged down an otherwise decent quarterly result.

But management apparently has a plan to combat these issues.

With a proposed initiative that could net Cann up to a 60% reduction in these manufacturing costs. Saving up to $23 million per year when their extraction process is at full capacity.

The catch, however, is that they need more money to put this plan into practice…

With management proposing a $20 million capital raise to realise these cost-saving measures, as well as provide some working capital for marketing and distribution efforts to accelerate growth opportunities.

As CEO Peter Cook explains:

We expect that the funding we are seeking via this capital raising will be sufficient to support our operations and expansion as we build our revenue base and move towards sustainable profitability.

While the past 12 months presented significant challenges in terms of COVID-related delays — particularly on the regulatory front — the Company has generated in excess of $4.2 million in revenues and has established key supply partnerships here in Australia and overseas.

What’s next for the Cann Group share price?

For investors, the key takeaway is to decide whether they want to be a part of this capital raise or not.

Cann has already secured half ($10 million) of the funds from institutional investors. Raising the funds at a 27.5-cent price, with some of Cann’s own directions also joining in.

Now, that same offer price is being extended to retail investors — giving them the chance to also pick up some discounted stock up to a certain limit.

So whether investors like it or not, their stock has already been diluted.

As for whether these funds will lead to a net positive result in the future, no one knows. But that is clearly what Cann’s management is hoping to do. Banking on the small, but growing, sales to continue climbing higher.

Does that mean you should buy Cann shares right now, though?

Tough to say, as it depends on your risk tolerance and appetite for volatility. What I can tell you, though, is that there are potentially better sectors and stocks to look out for. With companies that have far better fundamentals or growth prospects to be found in the small-cap space right now.

In fact, you can read all about it in our latest report. Including four small-cap picks that you can’t afford to ignore, right now.


Ryan Clarkson-Ledward,
For Money Morning

PS: Our publication Money Morning is a fantastic place to start on your investment journey. We talk about the big trends driving the most innovative stocks on the ASX. Learn all about it here

About Ryan Clarkson-Ledward

Ryan Clarkson-Ledward is an Editor at Money Morning.

Ryan holds degrees in both communication and international business. He helps bring Money Morning readers the latest market updates, both locally and abroad. Ryan tackles all the issues investors need to know about that the mainstream media neglects.

Ryan is also the Editor…

Cann Group Share Price Rises on Positive News 12.86% (ASX:CAN)

At the time of writing shares of Cann Group Ltd (ASX:CAN) trade at 39.5 cents, up 12.86%. The CAN share price was up on news the medical cannabis company gained approval for new banking debt facilities…

Elixinol Share Price Down: Two Thoughts on its Future

After going to almost $6 a share, it is going for almost a tenth of this price today. We look at what has happened to the Elixinol share price and the company’s restructure.

Why ASX Cannabis Stocks are Down — Should You Invest?

It’s been a tough year for ASX cannabis stocks with many companies shedding value over a 12-month window. Only Althea has emerged from the last year with a gain to show for it. It’s worth taking a look at the ETFMG Alternative Harvest ETF chart to see what’s happening to cannabis stocks globally….

CAN Share Price in the Red: Should You Avoid Large Cannabis Companies?

Indeed, the cannabis craze does appear to be dying down in recent months. But this doesn’t mean the sector no longer has potential. Perhaps it just means bigger isn’t always better when it comes to pot stocks.

Cann Group Share Price Up on Licence (ASX:CAN)

The Cann Group got manufacturing licenses for their facilities in Melbourne today, but their main focus will be on the Canadian market. We look at their valuation…

Cann Group Share Price Up on New Facility & Offtake Agreement

The latest news out of the company is that it has reached an agreement to purchase a site in the Mildura region as well as the announcement of a five-year offtake agreement with Aurora Cannabis.